Insmed Share Holder Equity 2006-2019 | INSM

Insmed share holder equity from 2006 to 2019. Share holder equity can be defined as the sum of preferred and common equity items
Insmed Annual Share Holder Equity
(Millions of US $)
2019 $262
2018 $208
2017 $361
2016 $154
2015 $312
2014 $186
2013 $143
2012 $121
2011 $134
2010 $193
2009 $124
2008 $-3
2007 $11
2006 $14
2005 $11
Insmed Quarterly Share Holder Equity
(Millions of US $)
2019-12-31 $262
2019-09-30 $304
2019-06-30 $357
2019-03-31 $144
2018-12-31 $208
2018-09-30 $291
2018-06-30 $371
2018-03-31 $435
2017-12-31 $361
2017-09-30 $421
2017-06-30 $83
2017-03-31 $122
2016-12-31 $154
2016-09-30 $218
2016-06-30 $251
2016-03-31 $282
2015-12-31 $312
2015-09-30 $339
2015-06-30 $365
2015-03-31 $165
2014-12-31 $186
2014-09-30 $199
2014-06-30 $112
2014-03-31 $132
2013-12-31 $143
2013-09-30 $157
2013-06-30 $105
2013-03-31 $108
2012-12-31 $121
2012-09-30 $137
2012-06-30 $120
2012-03-31 $128
2011-12-31 $134
2011-09-30 $142
2011-06-30 $177
2011-03-31 $186
2010-12-31 $193
2010-09-30 $125
2010-06-30 $124
2010-03-31 $124
2009-12-31 $124
2009-09-30 $121
2009-06-30 $121
2009-03-31 $116
2008-12-31 $-3
2008-09-30 $1
2008-06-30 $3
2008-03-31 $7
2007-12-31 $11
2007-09-30 $14
2007-06-30 $18
2007-03-31 $4
2006-12-31 $14
2006-09-30 $34
2006-06-30 $46
2006-03-31 $55
2005-12-31 $11
2005-09-30 $6
2005-06-30 $9
2005-03-31 $18
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.661B $0.136B
Insmed is a biopharmaceutical company engaged in the development and commercialization of ARIKAYCE, or liposomal amikacin for inhalation, for at least two identified orphan patient populations: patients with nontuberculous mycobacteria (NTM) lung infections and cystic fibrosis (CF) patients with Pseudomonas aeruginosa lung infections. Insmed is also focused on the development of INS1009, the company's inhaled treprostinil prodrug for the treatment of pulmonary arterial hypertension (PAH), a chronic, life-threatening disorder characterized by abnormally high blood pressure in the arteries between the heart and lungs.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $117.071B 13.38
Gilead Sciences (GILD) United States $92.991B 12.03
CSL (CSLLY) Australia $85.089B 0.00
Vertex Pharmaceuticals (VRTX) United States $58.203B 52.82
Biogen (BIIB) United States $53.079B 9.06
Regeneron Pharmaceuticals (REGN) United States $49.761B 21.08
Illumina (ILMN) United States $40.340B 41.71
Seattle Genetics (SGEN) United States $20.006B 0.00
Alexion Pharmaceuticals (ALXN) United States $19.071B 8.87
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.120B 0.00
Incyte (INCY) United States $15.835B 33.98
BioMarin Pharmaceutical (BMRN) United States $14.869B 635.69
BioNTech SE (BNTX) Germany $12.444B 0.00
Genmab (GNMSF) Denmark $12.338B 39.68
Galapagos (GLPG) Belgium $12.125B 26.48
Alnylam Pharmaceuticals (ALNY) United States $12.122B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.935B 46.43
QIAGEN (QGEN) Netherlands $9.295B 28.34
Moderna (MRNA) United States $9.192B 0.00
Exact Sciences (EXAS) United States $9.010B 0.00
BeiGene (BGNE) Cayman Islands $8.226B 0.00
Sarepta Therapeutics (SRPT) United States $7.701B 0.00
Bio-Techne Corp (TECH) United States $7.146B 48.90
Guardant Health (GH) United States $6.713B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.139B 0.00
Ascendis Pharma (ASND) Denmark $5.402B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.400B 14.27
Exelixis (EXEL) United States $5.277B 16.94
ARGENX SE-ADR (ARGX) Netherlands $5.056B 0.00
Reata Pharmaceuticals (RETA) United States $4.948B 0.00
Amarin (AMRN) Ireland $4.894B 0.00
Repligen (RGEN) United States $4.761B 87.06
Acceleron Pharma (XLRN) United States $4.375B 0.00
China Biologic Products (CBPO) China $4.316B 25.62
MorphoSys AG (MOR) Germany $3.544B 0.00
Vir Biotechnology (VIR) United States $3.510B 0.00
Mirati Therapeutics (MRTX) United States $3.497B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.320B 0.00
Blueprint Medicines (BPMC) United States $3.308B 0.00
Adaptive Biotechnologies (ADPT) United States $3.307B 0.00
Global Blood Therapeutics (GBT) United States $3.163B 0.00
Zai Lab (ZLAB) China $3.056B 0.00
Emergent Biosolutions (EBS) United States $2.982B 20.70
NeoGenomics (NEO) United States $2.857B 123.86
Immunomedics (IMMU) United States $2.830B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.677B 45.35
Genmab (GMAB) Denmark $2.607B 10.23
Bluebird Bio (BLUE) United States $2.590B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.576B 0.00
Halozyme Therapeutics (HALO) United States $2.473B 0.00
MyoKardia (MYOK) United States $2.472B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.468B 0.00
Amicus Therapeutics (FOLD) United States $2.428B 0.00
Alkermes (ALKS) Ireland $2.271B 179.88
Intercept Pharmaceuticals (ICPT) United States $2.224B 0.00
RA PHARMCTL INC (RARX) United States $2.223B 0.00
Arena Pharmaceuticals (ARNA) United States $2.161B 5.63
Denali Therapeutics (DNLI) United States $2.034B 0.00
UniQure (QURE) Netherlands $1.989B 0.00
Alector (ALEC) United States $1.943B 0.00
Viela Bio (VIE) United States $1.928B 0.00
Eidos Therapeutics (EIDX) United States $1.862B 0.00
Principia Biopharma (PRNB) United States $1.838B 0.00
Epizyme (EPZM) United States $1.785B 0.00
Fate Therapeutics (FATE) United States $1.770B 0.00
Arvinas (ARVN) United States $1.612B 0.00
Zymeworks (ZYME) Canada $1.491B 0.00
Akcea Therapeutics (AKCA) United States $1.460B 31.39
Dicerna Pharmaceuticals (DRNA) United States $1.350B 0.00
REGENXBIO (RGNX) United States $1.209B 0.00
Ligand Pharmaceuticals (LGND) United States $1.204B 37.40
Coherus BioSciences (CHRS) United States $1.186B 14.11
Editas Medicine (EDIT) United States $1.152B 0.00
Myriad Genetics (MYGN) United States $1.109B 19.58
Twist Bioscience (TWST) United States $1.072B 0.00
Zealand Pharma (ZEAL) Denmark $1.044B 0.00
Inovio Pharmaceuticals (INO) United States $1.042B 0.00
NextCure (NXTC) United States $1.029B 0.00
PHARMA MAR SA (PHMMF) Spain $0.985B 0.00
Adverum Biotechnologies (ADVM) United States $0.963B 0.00
NGM Biopharmaceuticals (NGM) United States $0.949B 0.00
Zealand Pharma (ZLDPF) Denmark $0.881B 0.00
Revance Therapeutics (RVNC) United States $0.867B 0.00
Intra-Cellular Therapies (ITCI) United States $0.861B 0.00
Sangamo Therapeutics (SGMO) United States $0.774B 0.00
Athenex (ATNX) United States $0.706B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.698B 0.00
Cytokineticsorporated (CYTK) United States $0.680B 0.00
Frequency Therapeutics (FREQ) United States $0.675B 0.00
Pharming Group (PHGUF) Netherlands $0.670B 0.00
Novavax (NVAX) United States $0.656B 0.00
Intellia Therapeutics (NTLA) United States $0.651B 0.00
Kadmon Holdings (KDMN) United States $0.649B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.625B 0.00
Cara Therapeutics (CARA) United States $0.623B 0.00
Codexis (CDXS) United States $0.618B 0.00
Retrophin (RTRX) United States $0.613B 0.00
Intrexon (PGEN) United States $0.582B 0.00
Arcus Biosciences (RCUS) United States $0.577B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.575B 0.00
GENFIT S.A (GNFT) France $0.550B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.537B 0.00
Bellus Health (BLU) Canada $0.524B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.502B 4.41
ANI Pharmaceuticals (ANIP) United States $0.492B 8.88
Compugen (CGEN) Israel $0.491B 0.00
MeiraGTx Holdings (MGTX) United States $0.485B 0.00
Castle Biosciences (CSTL) United States $0.483B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Heska (HSKA) United States $0.457B 0.00
Vericel (VCEL) United States $0.451B 66.93
Scholar Rock Holding (SRRK) United States $0.449B 0.00
AC Immune SA (ACIU) Switzerland $0.449B 10.38
Cel-Sci (CVM) United States $0.444B 0.00
DBV Technologies S.A (DBVT) France $0.437B 0.00
Mesoblast (MESO) Australia $0.436B 0.00
MiMedx (MDXG) United States $0.415B 0.00
Anika Therapeutics (ANIK) United States $0.413B 14.22
Morphic Holding (MORF) United States $0.411B 0.00
Verastem (VSTM) United States $0.406B 0.00
Prothena (PRTA) Ireland $0.404B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.400B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.400B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.398B 0.00
AnaptysBio (ANAB) United States $0.397B 0.00
Clovis Oncology (CLVS) United States $0.397B 0.00
Agenus (AGEN) United States $0.394B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.379B 0.00
Cue Biopharma (CUE) United States $0.378B 0.00
PDL BioPharma (PDLI) United States $0.373B 11.19
Adaptimmune Therapeutics (ADAP) United Kingdom $0.372B 0.00
Merus (MRUS) Netherlands $0.372B 0.00
Cellectis S.A (CLLS) France $0.370B 0.00
UROGEN PHARMA (URGN) United States $0.368B 0.00
Puma Biotechnology (PBYI) United States $0.357B 0.00
WAVE Life Sciences (WVE) Singapore $0.349B 0.00
NantKwest (NK) United States $0.342B 0.00
Sorrento Therapeutics (SRNE) United States $0.339B 0.00
BioDelivery Sciences (BDSI) United States $0.338B 39.00
Pfenex (PFNX) United States $0.332B 485.50
Athersys (ATHX) United States $0.315B 0.00
Precision BioSciences (DTIL) United States $0.310B 0.00
Cellular Biomedicine (CBMG) United States $0.310B 0.00
Dynavax Technologies (DVAX) United States $0.309B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.302B 0.00
CytomX Therapeutics (CTMX) United States $0.293B 0.00
Mersana Therapeutics (MRSN) United States $0.291B 0.00
Kala Pharmaceuticals (KALA) United States $0.283B 0.00
Avid Bioservices (CDMO) United States $0.280B 0.00
Albireo Pharma (ALBO) United States $0.278B 0.00
ADMA Biologics Inc (ADMA) United States $0.269B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.257B 0.00
Seres Therapeutics (MCRB) United States $0.249B 0.00
Kamada (KMDA) Israel $0.247B 10.26
Syros Pharmaceuticals (SYRS) United States $0.246B 0.00
Sutro Biopharma (STRO) United States $0.245B 0.00
MannKind (MNKD) United States $0.234B 0.00
Alcobra (ARCT) United States $0.231B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.226B 0.00
Gritstone Oncology (GRTS) United States $0.226B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.225B 0.00
Geron (GERN) United States $0.224B 0.00
Aduro Biotech (ADRO) United States $0.221B 0.00
Stemline Therapeutics (STML) United States $0.214B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.209B 1.88
OSMOTICA PHARM (OSMT) United States $0.196B 0.00
HOOKIPA Pharma (HOOK) United States $0.192B 0.00
XOMA (XOMA) United States $0.190B 0.00
Selecta Biosciences (SELB) United States $0.185B 0.00
VBI Vaccines (VBIV) United States $0.182B 0.00
IVERIC Bio (ISEE) United States $0.180B 0.00
ChromaDex (CDXC) United States $0.179B 0.00
Kindred Biosciences (KIN) United States $0.177B 0.00
Abeona Therapeutics (ABEO) United States $0.176B 0.00
Protagonist Therapeutics (PTGX) United States $0.173B 0.00
Spero Therapeutics (SPRO) United States $0.164B 0.00
Biofrontera AG (BFRA) Germany $0.159B 0.00
Arbutus Biopharma (ABUS) Canada $0.156B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.151B 0.00
Cerecor (CERC) United States $0.150B 0.00
Prometic Life Sciences (LMNL) Canada $0.150B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.150B 0.00
Starpharma Holdings (SPHRY) Australia $0.149B 0.00
VolitionRX (VNRX) United States $0.149B 0.00
POXEL SA FRANCE (PXXLF) France $0.145B 0.00
Liquidia Technologies (LQDA) United States $0.138B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.135B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.135B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.134B 5.27
Fortress Biotech (FBIO) United States $0.134B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Windtree Therapeutics (WINT) United States $0.134B 0.00
VTv Therapeutics (VTVT) United States $0.132B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.124B 0.00
Theratechnologies (THTX) Canada $0.124B 0.00
Dyadic (DYAI) United States $0.122B 0.00
Antibe Therapeutics (ATBPF) Canada $0.120B 0.00
Affimed (AFMD) Germany $0.120B 0.00
Exicure (XCUR) United States $0.119B 0.00
Enzo Biochem (ENZ) United States $0.118B 0.00
Strongbridge Biopharma (SBBP) United States $0.110B 0.00
Palatin Technologies (PTN) United States $0.108B 2.94
Celyad SA (CYAD) Belgium $0.106B 0.00
AIT Therapeutics (XAIR) United States $0.104B 0.00
CorMedix Inc (CRMD) United States $0.100B 0.00
Cidara Therapeutics (CDTX) United States $0.100B 0.00
Northwest Biotherapeutics (NWBO) United States $0.099B 0.00
OvaScience (MLND) United States $0.099B 0.00
Checkpoint Therapeutics (CKPT) United States $0.097B 0.00
Aptinyx (APTX) United States $0.097B 0.00
Five Prime Therapeutics (FPRX) United States $0.093B 0.00
PHASEBIO PHARMA (PHAS) United States $0.092B 0.00
IBio (IBIO) United States $0.091B 0.00
TELA Bio (TELA) United States $0.091B 0.00
Cyclerion Therapeutics (CYCN) United States $0.090B 0.00
Clearside Biomedical (CLSD) United States $0.083B 0.00
ARAVIVE, INC (ARAV) United States $0.078B 0.00
Happiness Biotech Group (HAPP) China $0.077B 0.00
Menlo Therapeutics (MNLO) United States $0.077B 0.00
Vaccinex (VCNX) United States $0.072B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.072B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.069B 0.00
SESEN BIO, INC (SESN) United States $0.068B 0.00
Aytu Bioscience (AYTU) United States $0.067B 0.00
Adocia (ADOCY) France $0.066B 0.00
Applied Genetic Technologies (AGTC) United States $0.066B 0.00
Proteostasis Therapeutics (PTI) United States $0.065B 0.00
Synlogic (SYBX) United States $0.065B 0.00
Orgenesis (ORGS) United States $0.062B 3.66
Eton Pharmaceuticals (ETON) United States $0.060B 0.00
Trevena (TRVN) United States $0.059B 0.00
AquaBounty Technologies (AQB) United States $0.059B 0.00
Pluristem Therapeutics (PSTI) Israel $0.058B 0.00
Catalyst Biosciences (CBIO) United States $0.057B 0.00
Emmaus Life Sciences (EMMA) United States $0.056B 0.00
Acorda Therapeutics (ACOR) United States $0.053B 0.00
Vascular Biogenics (VBLT) Israel $0.052B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.049B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.049B 0.00
Idera Pharmaceuticals (IDRA) United States $0.042B 0.00
Soligenix (SNGX) United States $0.038B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.037B 0.00
Organovo Holdings (ONVO) United States $0.037B 0.00
AmpliPhi Biosciences (ARMP) United States $0.036B 0.00
Advaxis (ADXS) United States $0.036B 0.00
Lumos Pharma (LUMO) United States $0.035B 0.00
Protalix BioTherapeutics (PLX) Israel $0.035B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.034B 0.00
TOCAGEN INC (TOCA) United States $0.034B 0.00
DiaMedica Therapeutics (DMAC) United States $0.034B 0.00
CollPlant Holdings (CLGN) Israel $0.034B 0.00
Prima BioMed (IMMP) Australia $0.030B 0.00
Signal Genetics (MGEN) United States $0.030B 0.00
Celldex Therapeutics (CLDX) United States $0.029B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.029B 0.00
Evogene (EVGN) Israel $0.028B 0.00
Curis (CRIS) United States $0.027B 0.00
Entera Bio (ENTX) Israel $0.027B 0.00
VistaGen Therapeutics (VTGN) United States $0.024B 0.00
Alimera Sciences (ALIM) United States $0.023B 0.00
Novogen (KZIA) Australia $0.022B 0.00
Pulmatrix (PULM) United States $0.021B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.021B 0.00
Celsion (CLSN) United States $0.021B 0.00
Stellar Biotechnologies (EDSA) Canada $0.019B 0.00
Apricus Biosciences (SEEL) United States $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.019B 0.00
BioCardia (BCDA) United States $0.019B 0.00
Oncobiologics (OTLK) United States $0.018B 0.00
Titan Pharmaceuticals (TTNP) United States $0.017B 0.00
Bionano Genomics (BNGO) United States $0.017B 0.00
Unum Therapeutics (UMRX) United States $0.015B 0.00
Aptevo Therapeutics (APVO) United States $0.012B 0.00
AEterna Zentaris (AEZS) United States $0.012B 0.00
ATyr Pharma (LIFE) United States $0.012B 0.00
TrovaGene (TROV) United States $0.010B 0.00
VIVUS (VVUS) United States $0.010B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
MYOS RENS Technology (MYOS) United States $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
TRACON Pharmaceuticals (TCON) United States $0.009B 0.00
Cesca Therapeutics (THMO) United States $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.007B 0.00
IMMURON (IMRN) Australia $0.007B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
Neuralstem (SNCA) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Spherix (AIKI) United States $0.003B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00